Study on Innovation Behavior of State-owned Pharmaceutical Enterprises Based on the Viewpoint of Ownership Structure Reforming


  •  Shengyi Shi    
  •  Guangping Wang    
  •  Yanfei Huo    
  •  Baxian Yi    
  •  Xiaoming Wu    

Abstract

It is necessary to play a leading and exemplary role in the implementation of Chinese innovative development strategy, because of the economic, social and political status of state-owned pharmaceutical enterprises. Based on describing pharmaceutical ownership reforming and innovation status, the paper analyzed the dynamic innovation performance of the State-owned pharmaceutical enterprises by the Malmquist index of DEA (Data Envelopment Analysis), and result shows that the biological product field of state-owned enterprises obtained better innovation performance. Then the paper discussed the innovation performance of state-owned pharmaceutical enterprises by the empirical analysis of Panel data model, the results showed that the state-owned enterprise have the serious status of R&D resource concentrating and excessing, but it is still achieve major force of Chinese pharmaceutical economic growth based on innovative activities. At last, the paper offered the upgrading road of state-owned enterprises innovation capability, such as the market radiating and integrating, micro-cooperation, organizational restructuring, and cross-regional integration.


This work is licensed under a Creative Commons Attribution 4.0 License.